Perfusion MRI by means of dynamic contrast-enhanced T2-weighted MR imaging allows quantitative analysis of cerebral blood volume (CBV) and mean transit time (MTT) in intraaxial brain tumors. Our aim was to compare recurrent glioblastomas to untreated glioblastomas, determining if there are differences in perfusion parameters between the two groups. Serial MR examinations were performed in 26 patients with glioblastoma histologically demonstrated before surgical resection and in 19 patients with recurrent glioblastoma after surgery and radiotherapy. Tumor recurrence was established using both histological and clinical criteria. Normalized CBV and MTT ratios were considered and compared between the two groups. A statistically significant difference, both in average and maximum normalized CBV ratios between the two groups was found. In particular, average and maximum normalized CBV ratios were greater in untreated than in recurrent glioblastomas. On the contrary, average and maximum normalized MTT ratios were greater in the recurrent glioblastomas, than in untreated tumors. Perfusion MRI by means of dynamic contrast-enhanced T2-weighted MR imaging is a valuable adjunct to conventional MR imaging in assessing different hemodynamic features between untreated and recurrent glioblastomas. In particular, tumor recurrence must be suspected even if the average and maximum normalized CBV ratios are far below those of untreated glioblastomas. In addition, increased average and maximum MTT ratios could be considered typical markers of neoplastic recurrence in irradiated cerebral tissue.
SamnickSBaderJBHellwigD: Clinical value of iodine-123-alpha-methyl-L-tyrisine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol20: 396–404, 2002.
6.
LanglebenDDSegallGM: PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med41: 1861–1867, 2000.
7.
SchlemmerHPBachertPHenzeM: Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology44: 216–222, 2002.
8.
SugaharaTKorogiYTomiguchiS: Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol21: 901–909, 2000.
9.
HeinPAEskeyCJDunnJF: Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: Tumor recurrence versus radiation injury. Am J Neuroradiol25: 201–209, 2004.
10.
RabinovJDLeePLBarkerFG: In vivo 3-T spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience. Radiology225: 871–879, 2002.
11.
WeybrightPMalyPGomez-HassanD: MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment. Neuroradiology46: 541–549, 2004.
12.
ChaS: Update on Brain Tumor Imaging: From Anatomy to Physiology. Am J Neuroradiol27: 475–487, 2006.
13.
JanusTJKimEETilburyR: Use of [18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol33: 540–548, 1993.
14.
Di ChiroGDeLaPlazRLBrooksRA: Glucose utilization of cerebral gliomas measured by F-18-fluorodeoxyglucose and positron emission tomography. Neurology32: 1323–1329, 1982.
15.
DeLaPlazRLPatronasNJBrooksRA: Positron emission tomography study of gray-matter glucose utilization by brain tumors. Am J Neuroradiol22: 826–829, 1983.
16.
Di ChiroG: Positron emission tomography using F-18-fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol22: 360–371, 1983.
17.
AronenHJGazitIELouisDN: Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology191: 41–51, 1994.
18.
SugaharaTKorogyYKochiM: Relationship of MR determined cerebral blood volume maps with histologic and angiographic vascularities of gliomas. Am J Roentgenol171: 1479–1486, 1998.
GriebelJMayrNAde VriesA: Assessment of tumor microcirculation: A new role of dynamic contrast MR imaging. J Magn Reson Imaging7: 111–119, 1997.
21.
JacksonAKassnerAAnnesley-WilliamsD: Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: Comparison with relative blood volume and tumor grade. Am J Neuroradiol23: 7–14, 2002.
22.
UematsuHMaedaMSadatoN: Vascular permeability: Quantitative measurements with double-echo dynamic MR imaging-Theory and clinical application. Radiology214: 912–917, 2000.
23.
SugaharaTKorogiYKochiM: Perfusion-sensitive MR imaging of gliomas: Comparison between gradient-echo and spin-echo echo-planar imaging techniques. Am J Neuroradiol22: 1306–1315, 2001.
24.
ProvenzaleJMWangGRBrennerT: Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. Am J Roentgenol178: 711–716, 2002.
25.
KovarDALewisMKarczmarGS: A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissue. J Magn Reson Imaging8: 1126–1134, 1998.
26.
SchmaindaKMRandSDJosephAM: Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and ngiogenesis. Am J Neuroradiol25: 1424–1532, 2004.
27.
ForsythPAKellyPJCascinoTL: Radiation necrosis or glioma recurrence: Is computer-assisted stereotactic biopsy useful?J Neurosurg82: 436–444, 1995.
28.
WenzFRemppKHessT: Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue. Quantification with dynamic susceptibility contrast MR imaging. Am J Roentgenol166: 187–193, 1996.
29.
PardoFSAronenHJKennedyD: Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. Int J Radiat Oncol Biol Phys30: 663–669, 1994.
30.
HeilandSBennerTDebusJ: Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain barrier. Magn Reson Imaging17: 21–27, 1999.
31.
WeisskoffRRosenBR: Functional magnetic resonance imaging. Acad Radiol2: 133–135, 1995.
WeisskoffRMCheslerDBoxermanJL: Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time?Magn Reson Med29: 553–559, 1993.
35.
MeierPZierlerKN: On the theory of the indicator-diluition method for measurement of blood flow and volume. J Appl Phisiol6(12): 731–744, 1954.
36.
BoxermanJLSchmaindaKMWeisskoffRM: Relative Cerebral Blood Volume Maps Corrected for Contrast Agent Extravasation Significantly Correlate with Glioma Tumor Grade, Whereas Uncorrected Maps Do Not. Am J Neuroradiol27: 859–867, 2006.
37.
ChaSKnoppEAJohnsonG: Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatino. Am J Neuroradiol21: 881–890, 2000.
38.
FolkmanJ: What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst82: 4–6, 1989.
39.
YoshiiYPhillipsTL: Late vascular effects of the whole brain X-irradiation in the mouse. Acta Neurochir64: 87–102, 1982.
40.
GutinPHLeibelSAShelineGE: Radiation Injury to the Nervous System. Raven, New York1991.
41.
ValkPEDillonWP: Radiation injury of the brain. Am J Neuroradiol12: 45–62, 1991.
42.
CurranWJHecht-LeavittCSchutL: Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys13: 1093–1098, 1987.
LundqvistHRosanderKLomanovM: Permeability of the blood-brain barrier in the rat after local proton irradiation. Acta Radiol Oncol21: 267–271, 1982.
45.
MiotEHoffschirDAlapettieC: Experimental MR study of cerebral radiation injury: Quantitative T2 changes over time and histopathologic correlation. Am J Neuroradiol16: 79–85, 1995.
46.
Di ChiroGOldfieldEWrightDC: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am J Roentgenol150: 189–197, 1988.
47.
HaymakerWIbrahimMZMiquelJ: Delayed radiation effects in the brains of monkeys exposed to X- and g-rays. J Neuropathol Exp Neurol27: 50–79, 1968.
48.
GaenslerEHLDillonWPEdwardsMSB: Radiation-induced teleangiectasia in the brain simulates cryptic vascular malformations at MR imaging. Radiology193: 629–636, 1994.
49.
OkedaRShibataT: Radiation encephalopathy: An autopsy case and some comments on the pathogenesis of delayed radionecrsis of the central nervous system. Acta Pathol Jpn23: 867–883, 1963.
50.
ShinJHLeeHKKwunBD: Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: Preliminary results. Am J Roentgenol179: 783–789, 2002.
